SCHEMBL32665834

SCHEMBL32665834

NC(=S)Sc1ccc(Cl)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ITGB2 P05107 2/20 0.47
▸ ICAM1 P05362 2/20 0.47
▸ ITGAL P20701 2/20 0.47
▸ HSD17B10 Q99714 3/20 0.40
▸ TSHR P16473 2/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ HTT P42858 4/20 0.40
▸ IDO1 P14902 3/20 0.40
▸ TP53 P04637 1/20 0.39
▸ MAPT P10636 3/20 0.39
▸ ALDH1A1 P00352 4/20 0.38
▸ HPGD P15428 2/20 0.38
▸ ALOX15 P16050 2/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ ITGB3 P05106 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11771106 0.81 GAA (0.47) HSD17B10CYP3A4HTTMAPTALDH1A1
Trimethylammonium SCHEMBL11775950 0.77 GAA (0.44) CYP3A4HTTMAPTALDH1A1HPGD
SCHEMBL21807618 0.75 PKM (0.44) TSHRHTTIDO1MAPTALDH1A1
SCHEMBL11773006 0.72 GAA (0.40) CYP3A4MAPTALDH1A1SMN1; SMN2MEN1
SCHEMBL23709692 0.72 ITGB2 (0.43) ITGB2ICAM1ITGALHSD17B10TSHR
SCHEMBL5044607 0.72 ITGB2 (0.55) ITGB2ICAM1ITGALHSD17B10TSHR
SCHEMBL10834427 0.72 ITGB2 (0.50) ITGB2ICAM1ITGALHSD17B10TSHR
SCHEMBL3165346 0.71 ITGB2 (0.72) ITGB2ICAM1ITGALHSD17B10TSHR
SCHEMBL30472043 0.71 FBP1 (0.58) ITGB2ICAM1ITGALHSD17B10TSHR
SCHEMBL224671 0.71 FBP1 (0.58) ITGB2ICAM1ITGALHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12534440-B2 Compounds with copper- or zinc-activated toxicity against microbial infection KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 2026-01-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12534440-B2 Compounds with copper- or zinc-activated toxicity against microbial infection TST, SLC39A11, SLC39A3 ITGB2 4204/4885ICAM1 3831/4885ITGAL 4225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback